Hesham Allam, MD

Associate Professor
Neurology

    About me

    Gender

    Male

    Additional languages spoken

    Arabic

    Education & training

    Positions
    Neurologist
    Board Certifications
    Neurology
    Medical School
    Ain Shams University School of Medicine, Cairo, Egypt
    Residency
    Neurology and Psychiatry, Saint Louis University Hospital, Saint Louis, MO
    Fellowship
    Neurocritical Care, Rush University Medical Center, Chicago, IL
    Vascular Neurology, Washington University School of Medicine, St. Louis, IL

    Clinical trials

    Trial
    Neuroscience Institute

    Sleep for Stroke Management and Recovery Trial

    Active recruiting

    The primary goals of this study are to determine whether treatment of obstructive sleep apnea with positive airway pressure starting shortly after accute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event and (2) improves stroke outcomes at 3 months in patients who experienced ischemic stroke.

    Trial
    Neuroscience Institute

    18-513: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    18-513:  The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.